Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro‐Esli
暂无分享,去创建一个
[1] Villanueva Vicente,et al. THUR 058 Eslicarbazepine acetate as monotherapy in clinical practice , 2018, Journal of Neurology Neurosurgery & Psychiatry.
[2] D. Costello,et al. Real world experience with lacosamide monotherapy- a single center 1-year follow-up study , 2018, Epilepsy Research.
[3] M. De Backer,et al. Lacosamide monotherapy in clinical practice: A retrospective chart review , 2018, Acta neurologica Scandinavica.
[4] C. Elger,et al. Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study , 2018, Epilepsia.
[5] N. Delanty,et al. Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures , 2017, Journal of Neurology.
[6] J. Ojeda,et al. EARLY‐ESLI study: Long‐term experience with eslicarbazepine acetate after first monotherapy failure , 2017, Acta neurologica Scandinavica.
[7] R. Toledano,et al. Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study , 2017, Epilepsy & Behavior.
[8] J. Chaves,et al. Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study , 2017, Acta neurologica Scandinavica.
[9] M. Holtkamp,et al. Daten zum aktuellen Praxiseinsatz von Eslicarbazepinacetat in Deutschland , 2016, Zeitschrift für Epileptologie.
[10] M. Holtkamp,et al. Real‐world data on eslicarbazepine acetate as add‐on to antiepileptic monotherapy , 2016 .
[11] T. Mayer,et al. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study , 2015, Epilepsia.
[12] R. Rocamora,et al. Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests , 2015, Epilepsy Research.
[13] L. Pazdera,et al. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study , 2015, BMC Neurology.
[14] M. Sperling,et al. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America , 2015, Epilepsia.
[15] J. Chaves,et al. Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study , 2014, Epilepsy Research.
[16] J. Serratosa,et al. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study , 2014, Epilepsy Research.
[17] J. Roquer,et al. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results. , 2014, Neurologia.
[18] R. Rocamora,et al. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results☆☆☆ , 2014 .
[19] M. Brodie,et al. Safety and efficacy of eslicarbazepine acetate (zebinix) in everyday clinical practice using a retrospective multicentre audit , 2013, Journal of Neurological Sciences.
[20] M. Brodie,et al. Combining antiepileptic drugs—Rational polytherapy? , 2011, Seizure.
[21] J. Cramer,et al. The evolution of antiepileptic drug development and regulation , 2010, Epileptic disorders : international epilepsy journal with videotape.
[22] T. Egberts,et al. Clinical relevance of patients with epilepsy included in clinical trials , 2008, Epilepsia.
[23] G. Pauletto,et al. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice , 2006, Seizure.
[24] B. Passarella,et al. Long-term treatment with oxcarbazepine in clinical practice. , 2005, Functional neurology.
[25] M. Baulac. Rational conversion from antiepileptic polytherapy to monotherapy. , 2003, Epileptic disorders : international epilepsy journal with videotape.
[26] H. Meinardi,et al. Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse Effects , 1997, Epilepsia.